Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Di Feng
Institution:
Boehringer Ingelheim (Germany)
Observed institutions:
Boehringer Ingelheim (Germany),
Yale University,
Boehringer Ingelheim (United States)
ORCID:
0000-0002-0964-9995
Observed ORCID:
0000-0002-0964-9995
OpenAlex ID:
A5080879616
Single Cell Explorer, collaboration-driven tools to leverage large-scale single cell RNA-seq data
2019
·
Di Feng
, Charles E. Whitehurst
, et al.
·
BMC Genomics
·
27
PDF
Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with Combined SOS1 and MEK Inhibition for Improved Immunotherapy Response
2024
·
Robert J. Norgard
, Pratha Budhani
, et al.
·
Cancer Research Communications
·
17
PDF
Perturbation of calreticulin potentiates CD8+ T cell–mediated antitumor immunity
2025
·
Kaiyang Tang
, Lijian Wu
, et al.
·
The Journal of Experimental Medicine
·
10
PDF
Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
·
Cancer Research Communications
·
3
Incorporating prior information in gene expression network-based cancer heterogeneity analysis
2024
·
Rong Li
, Shaodong Xu
, et al.
·
Biostatistics
·
3
PDF
Deep learning for discovering pathological continuum of crypts and evaluating therapeutic effects: An implication for in vivo preclinical study
2021
·
Dechao Shan
, Jie Zheng
, et al.
·
PLoS ONE
·
3
PDF
Figure 5 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Figure 2 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Table 1 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Table 2 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Supplementary Figure 2 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Supplementary Figure 3 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Supplementary Figure 4 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Supplementary Table 1 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Data from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Figure 1 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Supplementary Table 3 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Figure 4 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Figure 3 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Supplementary Figure 1 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Supplementary Table 2 from Identification of Pancreatic Ductal Adenocarcinoma Extracellular Matrix Signatures from In-Depth Proteomic Profiling that Correlate with Lymphocyte Infiltration
2026
·
James M. Considine
, Dharma Pally
, et al.
Supplementary Figure S1 from TCPGdb: A Comprehensive T-cell Perturbation Genomics Database for the Identification of Critical T-cell Regulators
2026
·
Chuanpeng Dong
, Feifei Zhang
, et al.
Data from TCPGdb: A Comprehensive T-cell Perturbation Genomics Database for the Identification of Critical T-cell Regulators
2026
·
Chuanpeng Dong
, Feifei Zhang
, et al.
Supplementary Figure S2 from TCPGdb: A Comprehensive T-cell Perturbation Genomics Database for the Identification of Critical T-cell Regulators
2026
·
Chuanpeng Dong
, Feifei Zhang
, et al.
Supplementary Tables 1-6 from TCPGdb: A Comprehensive T-cell Perturbation Genomics Database for the Identification of Critical T-cell Regulators
2026
·
Chuanpeng Dong
, Feifei Zhang
, et al.
Show more works
View as search
Works count:
59
Citation count:
68
H-index:
3
I10-index:
3
Year
Topic
Type